Gilead to acquire remaining worldwide rights of breast cancer drug, Trodelvy
All of Everest Medicine's development and commercialization rights for a breast cancer drug called Trodelvy…
August 19, 2022 - 3 minutes
Gilead
Galapagos and Gilead Soldier On After Inflammatory Disease Flops
Clinical and regulatory setbacks have left the star biotech duo Gilead and Galapagos smarting and…
March 4, 2021 - 4 minutes
Galapagos’ Arthritis Drug Approved in EU and Japan Amid US Rejection
The recent EU and Japan approvals of the rheumatoid arthritis drug filgotinib contrast with the…
October 5, 2020 - 5 minutes
Remdesivir Becomes the First Covid-19 Treatment Approved in Europe
Remdesivir has received a one-year conditional marketing authorization from the European Commission due to the…
July 8, 2020 - 3 minutes
Gilead Pays Billions for Access to Galapagos’ Pipeline
Gilead has launched a 10-year collaboration with the Belgo-Dutch biotech Galapagos, paying at least €4.5B…
July 15, 2019 - 2 minutes
Belgian and US Biotechs Team up to Reduce CAR T Side Effects
The diagnostics company Biocartis is collaborating with Kite Pharma to monitor the progress of CAR…
June 3, 2019 - 3 minutes
Austrian Biopharma Reaches First HIV Vaccine Milestone
Hookipa Pharma has reached its first milestone in a partnership deal with US-based CAR T…
January 3, 2019 - 2 minutes
Galapagos and Gilead Launch the Fifth New Trial for Filgotinib this Year
With the addition of uveitis, Galapagos and Gilead are raising to 10 the number of…
July 5, 2017 - 1 minute
Dual HIV Therapy: GSK and Gilead Battle over Whose Drug is the Best
GSK announced Phase III results for dolutegravir, which could reduce triple HIV therapy down to…
February 14, 2017 - 2 minutes
Galapagos gets another Milestone Payment from Gilead
Galapagos is starting a new PhaseIIb/III clinical trial for ulcerative colitis that has triggered a €9.4M…
December 9, 2016 - 2 minutes
Galapagos Hangs On: Filgotinib enters Phase III for Rheumatoid Arthritis
After losing AbbVie as a partner, Galapagos has pressed on with Gilead in the development…
August 25, 2016 - 2 minutes
While working on its HIV Cure, Gilead gives Europe an ‘HIV Vaccine’
Despite progress in HIV treatments and towards an HIV cure, the infection rate has risen…
August 24, 2016 - 2 minutes
